ArticlePsoriasis (Auckland, N.Z.)2026
Persistence and Long-Term Disease Control of Interleukin-17 Inhibitors and Interleukin-23 Inhibitors in Patients with Psoriasis: A Nationwide Cohort Study in Japan.
Youran Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.